ANAVEX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 19 Mar 2024)
What this means for you
Registered since 29 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86768671
- Registration number
- 5273729
- Mark type
- Stylized text
- Filed
- 25 Sept 2015
- Published for opposition
- 13 Jun 2017
- Registered
- 29 Aug 2017
- Attorney of record
- Matthew Smith
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions including Alzheimer's disease
Owner
- Anavex Life Sciences Corp., New York, NY, US
- Anavex Life Sciences Corp., New York, NY, US
- Anavex Life Sciences Corp., New York, NY, US
Prosecution history
- 19 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Mar 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Feb 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 15 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 29 Aug 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 13 Jun 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jun 2017 — PUBLISHED FOR OPPOSITION
- 24 May 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 May 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 28 Apr 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jan 2017 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 26 Jul 2016 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED